Further investigation into the role of VAV2 in Enzalutamide resistance in PCa revealed that VAV2 knockdown increased cellular sensitivity to Enzalutamide, while VAV2 overexpression reversed this effect (Fig. 6A). Here, VAV2 is linked to posterior cortical atrophy.